<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03185234</url>
  </required_header>
  <id_info>
    <org_study_id>Uni-Koeln-3033</org_study_id>
    <secondary_id>U1111-1195-2536</secondary_id>
    <secondary_id>DRKS00012292</secondary_id>
    <nct_id>NCT03185234</nct_id>
  </id_info>
  <brief_title>Rehabilitating (Stroke-induced) Apraxia With Direct Current Stimulation</brief_title>
  <acronym>RAdiCS</acronym>
  <official_title>Therapeutischer Einsatz Der Schwachen Gleichstromstimulation (tDCS) Bei Motorisch-kognitiven Defiziten Nach Schlaganfall</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the clinical trial is to investigate whether weak transcranial direct
      current stimulation (tDCS) can ameliorate the motor cognitive deficit apraxia during stroke
      rehabilitation. Stroke patients with apraxia will either receive a real stimulation or a sham
      stimulation (placebo) for 10 minutes at a time on 5 consecutive days during their in-patient
      stay in a rehabilitation center. Additionally, motor tasks are performed before and after the
      stimulation. The effect of the weak current stimulation on motor function is assessed 3-4
      days after the last stimulation and 3 months after enrollment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite the high incidence of the motor cognitive deficit apraxia after left-hemispheric
      stroke, evidence-based therapies do not exist. This randomized controlled clinical trial
      (RCT) investigates whether anodal transcranial direct current stimulation (tDCS) as an add-on
      therapy during neuro-rehabilitation can ameliorate apraxic deficits in patients with left
      hemisphere stroke. Therefore, anodal tDCS is applied over the parietal cortex of the left,
      lesioned hemisphere with an intensity of 2 mA for 10 minutes at a time on 5 consecutive days
      in combination with motor tasks before and after the stimulation. The effect of the
      stimulation is compared to a sham stimulation. Moreover, application of a pre-programmed
      study mode ensures a double-blind study design (patient and investigator). The performance in
      the apraxia test KAS (Cologne Apraxia Screening) 3-4 days after the last stimulation,
      compared to baseline, serves as primary endpoint of the study. Secondary endpoints are
      evaluated using various apraxia tests, motor tests and neuropsychological tests 3-4 days
      after the last stimulation and 3 months after enrollment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>KAS (Cologne Apraxia Screening)</measure>
    <time_frame>3-4 days after stimulation</time_frame>
    <description>Degree of apraxia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>KAS (Cologne Apraxia Screening)</measure>
    <time_frame>3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goldenberg Imitation</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>de Renzi Imitation</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>de Renzi actual tool use</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Jebsen Taylor Hand Function Test (JTHFT)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gripforce (Vigorimeter)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength of hands (MRC)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health Stroke Scale (NIHSS)</measure>
    <time_frame>enrollment</time_frame>
    <description>Impairment by stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Ranking Scale (mRS)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Impairment by stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aphasia Check List (ACL-K)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Aphasia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Stroke</condition>
  <condition>Apraxia</condition>
  <arm_group>
    <arm_group_label>Real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anodal tDCS at an intensity of 2 mA is applied for 10 minutes at a time on 5 consecutive days. The anodal electrode is placed over the left parietal cortex (P3 in 10/20 EEG) of the lesioned hemisphere, the cathodal electrode is located supraorbital on the right side. Motor tasks are performed before and after the stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation is applied for 10 minutes at a time on 5 consecutive days. One electrode is placed over the left parietal cortex (P3 in 10/20 EEG) of the lesioned hemisphere and a second electrode supraorbital on the right side. Motor tasks are performed before and after the stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>anodal tDCS</intervention_name>
    <description>2 mA, 10 min, 5 sessions</description>
    <arm_group_label>Real tDCS</arm_group_label>
    <other_name>neuroConn DCS, model no. 008</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>sham stimulation, 10 min, 5 sessions</description>
    <arm_group_label>Sham tDCS</arm_group_label>
    <other_name>neuroConn DCS, model no. 008</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  left hemispheric ischemic stroke in the subacute/ chronic phase (&gt;10 days and &lt;180
             days post-stroke)

          -  clinical confirmation of apraxia by KAS (Cologne Apraxia Screening), Cut-off ≤ 76/ 80
             points;

          -  age 18 - 90 years;

          -  written Informed Consent

        Exclusion Criteria:

          -  pregnancy, breastfeeding and women without exclusion of pregnancy

          -  patients with clinical manifestation of a stroke prior to the index-stroke

          -  malignant disease with affection of central nervous system

          -  life expectancy &lt;12 months

          -  current addiction to alcohol or drugs or other addictive disease (exception: nicotine)

          -  current clinically manifest psychiatric disorders, such as schizophrenia or severe
             depressive episode

          -  epileptic seizure within the past two years

          -  continuous medication during the intervention phase with benzodiazepine,
             antipsychotics of high potential and anti-epileptic drugs taken for prophylaxis of
             epileptic seizures

          -  enrollment in other studies with brain stimulation in the time period after the index
             stroke

          -  heart pacemaker

          -  electrodes for deep brain stimulation or other metal implants in the head (expected
             are dental fillings and inlays)

          -  craniectomy or trepanation

          -  vulnerable skin lesions at electrode positions

          -  poor motivation/ cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gereon R. Fink, Univ-Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gereon R. Fink, Univ-Prof.</last_name>
    <phone>+49-221-478 4000</phone>
    <email>gereon.fink@uk-koeln.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rehabilitationszentrum Godeshöhe e.V.</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karbe Hans, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Nina N. Kleineberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monika K. Richter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter H. Weiss, MD, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MediClin Fachklinik Rhein/Ruhr für Neurologie</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45219</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siebler Mario, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Monika K. Richter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nina N. Kleineberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter H. Weiss, MD, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2017</study_first_submitted>
  <study_first_submitted_qc>June 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Gereon R. Fink</investigator_full_name>
    <investigator_title>Univ.-Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>tDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Apraxias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

